Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report

Author(s): Hall, Deborah A; Forjaz, Maria Joao; Golbe, Lawrence I; Litvan, Irene; Payan, Christine Ann M; Goetz, Christopher G; Leentjens, Albert FG; Martinez-Martin, Pablo; Traon, Anne Pavy-Le; Sampaio, Cristina; Post, Bart; Stebbins, Glenn; Weintraub, Daniel; Schrag, Anette

[1]  J. Olszewski,et al.  Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia , 2014, Seminars in Neurology.

[2]  P. Martínez-Martín,et al.  How to Evaluate Validation Data , 2012 .

[3]  C. Jack,et al.  Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials. , 2012, Parkinsonism & related disorders.

[4]  R. Kinno,et al.  Can the ‘Head-Turning Sign’ Be a Clinical Marker of Alzheimer's Disease? , 2011, Dementia and Geriatric Cognitive Disorders Extra.

[5]  A. Kertesz,et al.  Extrapyramidal Syndromes in Frontotemporal Degeneration , 2011, Journal of Molecular Neuroscience.

[6]  Albert C. Ludolph,et al.  Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE , 2011, PloS one.

[7]  W. Oertel,et al.  Health-Related Quality of Life in Multiple System Atrophy and Progressive Supranuclear Palsy , 2011, Neurodegenerative Diseases.

[8]  Y. Agid,et al.  Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. , 2010, Brain : a journal of neurology.

[9]  Carlo Colosimo,et al.  Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations , 2010, Movement disorders : official journal of the Movement Disorder Society.

[10]  M. Jahanshahi,et al.  A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy , 2010, Movement disorders : official journal of the Movement Disorder Society.

[11]  C. Becker,et al.  Clinical and dual‐tasking aspects in frequent and infrequent fallers with progressive supranuclear palsy , 2010, Movement disorders : official journal of the Movement Disorder Society.

[12]  P. F. D. de Bruin,et al.  Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study. , 2010, Parkinsonism & related disorders.

[13]  W. Kamphorst,et al.  Survival in progressive supranuclear palsy and frontotemporal dementia , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  A. Kertesz,et al.  Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy , 2010, Journal of Neurological Sciences.

[15]  B. Borroni,et al.  Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy , 2009, International Psychogeriatrics.

[16]  Brit Mollenhauer,et al.  Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy. , 2009, Sleep medicine.

[17]  C. Schade-Brittinger,et al.  Short‐term effects of coenzyme Q10 in progressive supranuclear palsy: A randomized, placebo‐controlled trial , 2008, Movement disorders : official journal of the Movement Disorder Society.

[18]  W. Poewe,et al.  Scales to assess psychosis in Parkinson's disease: Critique and recommendations , 2008, Movement disorders : official journal of the Movement Disorder Society.

[19]  William W. McDonald,et al.  Depression rating scales in Parkinson's disease: Critique and recommendations , 2007, Movement disorders : official journal of the Movement Disorder Society.

[20]  L. Golbe,et al.  A clinical rating scale for progressive supranuclear palsy. , 2007, Brain : a journal of neurology.

[21]  Frans J Oort,et al.  Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations , 2006, BMC medical research methodology.

[22]  P. S. Mathuranath,et al.  Subcortical dementia revisited: Similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA) , 2005, Neurocase.

[23]  R. Howard,et al.  Measuring disability in patients with neurodegenerative disease using the ‘Yesterday Interview’ , 2004, International journal of geriatric psychiatry.

[24]  W. Poewe,et al.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[25]  M. Jahanshahi,et al.  Health‐related quality of life in patients with progressive supranuclear palsy , 2003, Movement disorders : official journal of the Movement Disorder Society.

[26]  T Wentzel-Larsen,et al.  Performance on the dementia rating scale in Parkinson’s disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[27]  S. Leurgans,et al.  Progression of gait, speech and swallowing deficits in progressive supranuclear palsy , 2003, Neurology.

[28]  Kathleenl N. Lohr,et al.  Assessing health status and quality-of-life instruments: Attributes and review criteria , 2002, Quality of Life Research.

[29]  Jane S. Paulsen,et al.  Neuropsychiatric assessment of Gilles de la Tourette patients: Comparative study with other hyperkinetic and hypokinetic movement disorders , 2001, Movement disorders : official journal of the Movement Disorder Society.

[30]  D. Royall,et al.  The FAB: A frontal assessment battery at bedside , 2001, Neurology.

[31]  R M Werner,et al.  The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[32]  I Litvan,et al.  Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. , 2001, The Journal of neuropsychiatry and clinical neurosciences.

[33]  S. Leurgans,et al.  Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale , 2000, Movement disorders : official journal of the Movement Disorder Society.

[34]  A. Lang,et al.  Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off‐state , 1999, Movement disorders : official journal of the Movement Disorder Society.

[35]  W. Weiner,et al.  Pramipexole in progressive supranuclear palsy , 1999, Neurology.

[36]  J E Ware,et al.  Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. , 1998, Journal of clinical epidemiology.

[37]  G. Stebbins,et al.  Factor structure of the unified Parkinson's disease rating scale: Motor examination section , 1998, Movement disorders : official journal of the Movement Disorder Society.

[38]  E. Mori,et al.  [Caregiver burden in dementia: evaluation with a Japanese version of the Zarit caregiver burden interview]. , 1998, No to shinkei = Brain and nerve.

[39]  R. Fitzpatrick,et al.  PDQ-39: a review of the development, validation and application of a Parkinson’s disease quality of life questionnaire and its associated measures , 1998, Journal of Neurology.

[40]  M. Hallett,et al.  International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome , 1997, Journal of the Neurological Sciences.

[41]  J. Hodges,et al.  Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy , 1996, Journal of Neurology.

[42]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[43]  Y. Agid,et al.  Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[44]  J. Hodges,et al.  The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy , 1994, Journal of Neurology.

[45]  M. Albert,et al.  Cognitive differences between patients with progressive supranuclear palsy and Alzheimer's disease. , 1989, Journal of clinical and experimental neuropsychology.

[46]  L. Golbe,et al.  Prevalence and natural history of progressive supranuclear palsy , 1988, Neurology.

[47]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[48]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[49]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[50]  D. Low,et al.  SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy. , 2012, Parkinsonism & related disorders.

[51]  C. Terwee,et al.  Quality criteria were proposed for measurement properties of health status questionnaires. , 2007, Journal of clinical epidemiology.

[52]  D. D. C. P. Mrcp,et al.  MRI derived brain atrophy in PSP and MSA-P , 2006, Journal of Neurology.

[53]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[54]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[55]  A. Kasuya.  EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[56]  S. Fahn.  Unified Parkinson's Disease Rating Scale , 1987 .

[57]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.